Acquiring Company
MannKind Corporation
Acquired Company
scPharma
DanburyBurlingtonBiotechnologyHealth CareManufacturingBiotechnologyHealth CarePharmaceuticalDescription
MannKind Corporation has completed its acquisition of scPharmaceuticals Inc. to enhance its growth in cardiometabolic care. The acquisition aims to integrate scPharmaceuticals' expertise and therapies, particularly FUROSCIX®, into MannKind's existing infrastructure. This strategic move is expected to strengthen MannKind's revenue streams and expand its market presence.
Quick answer
MannKind Corporation is acquiring scPharma, announced October 7, 2025. MannKind Corporation is based in Danbury, Connecticut, United States.
- How much did MannKind Corporation pay for scPharma?
- The deal value was not disclosed.
- What does MannKind Corporation do?
- MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung..
- Where are MannKind Corporation and scPharma based?
- MannKind Corporation is based in Danbury, Connecticut, United States. scPharma is based in Burlington, Massachusetts, United States.
- Who are the decision-makers at MannKind Corporation?
- Fundz holds 1 contact at MannKind Corporation. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie acquires Bretisilocin for mental health expansion (October 15, 2025)
- Avanos Medical acquires Nexus Medical for growth (September 15, 2025)
- XOMA Royalty acquires LAVA Therapeutics N.V. (November 21, 2025)
- ClearPoint Neuro acquires IRRAS for $5 million, $5M (November 20, 2025)
- LSL Pharma acquires Laboratoire Du-Var Inc. (November 18, 2025)
- Harrow acquires Melt Pharmaceuticals for sedation solutions (November 18, 2025)
Who to call at MannKind Corporation, and when
When MannKind Corporation changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day MannKind Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MannKind Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MannKind Corporation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MannKind Corporation makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired scPharma?
scPharma was acquired by MannKind Corporation, based in Danbury. The deal was reported on October 7, 2025. MannKind Corporation is publicly traded (MNKD) and operates in Biotechnology.
When did MannKind Corporation acquire scPharma?
MannKind Corporation's acquisition of scPharma was reported on October 7, 2025. MannKind Corporation has completed its acquisition of scPharmaceuticals Inc. to enhance its growth in cardiometabolic care. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does scPharma do?
scPharma is a biopharmaceutical company that develops drug-device combination products to address unmet medical needs. Their innovative solutions aim to improve patient adherence and outcomes through advanced delivery mechanisms. It is privately held, operating in Manufacturing, and is based in Burlington.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.